Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical study

Wilson X. Wang, Dan Spiegelman, Kumar Rao, Rennie L. Rhee, Andria L. Ford, Jonathan Miner, Rajendra S. Apte

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	The Journal of clinical investigation
Volume	134
Issue number	24
DOIs	https://doi.org/10.1172/JCI189023
State	Published - Dec 16 2024

Access to Document

@article{2850ad294548451c845ba80503470d9a,

title = "Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical study",

author = "Wang, {Wilson X.} and Dan Spiegelman and Kumar Rao and Rhee, {Rennie L.} and Ford, {Andria L.} and Jonathan Miner and Apte, {Rajendra S.}",

year = "2024",

month = dec,

day = "16",

doi = "10.1172/JCI189023",

language = "English",

volume = "134",

journal = "The Journal of clinical investigation",

issn = "0021-9738",

number = "24",

}

TY - JOUR

T1 - Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical study

AU - Wang, Wilson X.

AU - Spiegelman, Dan

AU - Rao, Kumar

AU - Rhee, Rennie L.

AU - Ford, Andria L.

AU - Miner, Jonathan

AU - Apte, Rajendra S.

PY - 2024/12/16

Y1 - 2024/12/16

UR - http://www.scopus.com/inward/record.url?scp=85212907030&partnerID=8YFLogxK

U2 - 10.1172/JCI189023

DO - 10.1172/JCI189023

M3 - Article

C2 - 39680465

AN - SCOPUS:85212907030

SN - 0021-9738

VL - 134

JO - The Journal of clinical investigation

JF - The Journal of clinical investigation

IS - 24

ER -